Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iKare Mood Trauma Recovery Clinic is a specialized mental health treatment center focused on providing advanced interventional psychiatry services for treatment-resistant conditions. The clinic offers a range of evidence-based therapies, including Transcranial Magnetic Stimulation (TMS), Ketamine infusion therapy, and Spravato (esketamine) nasal spray. Led by experienced psychiatric professionals, iKare specializes in treating complex mood disorders, post-traumatic stress disorder (PTSD), and severe depression. The facility emphasizes a holistic and personalized approach to mental wellness, integrating traditional psychiatric care with cutting-edge neurobiological treatments to help patients achieve long-term recovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iKare Mood Trauma Recovery Clinic.